Upjohn
Search results
Pharmacia & Upjohn was a global pharmaceutical company formed by the merger of Sweden-based Pharmacia AB and the American company Upjohn in 1995. Today the remainder of the company is owned by Pfizer. In 1997, Pharmacia & Upjohn sold several brands to Johnson & Johnson, including Motrin and Cortaid.
Learn how Pfizer and Pharmacia merged in 2003 to become the world's leading research-based pharmaceutical company. Explore the origins and achievements of both companies, from Carlo Erba to Searle, Upjohn and Monsanto.
An international manufacturer of pharmaceuticals formed through the 1995 merger of the Pharmacia A.B. and the Upjohn Company, Pharmacia & Upjohn Inc. researches, develops, manufactures, and markets a variety of pharmaceutical and health-related products, including those for infectious and metabolic diseases, central nervous system disorders ...
Pfizer announced the completion of the transaction to separate its Upjohn business and combine it with Mylan N.V. to create Viatris Inc. in November 2020. The transaction was structured as an all-stock Reverse Morris Trust and resulted in Pfizer stockholders owning approximately 57% of Viatris shares.
The Upjohn Company was an American pharmaceutical manufacturing firm founded in 1886 in Hastings, Michigan, by Dr. William E. Upjohn who was an 1875 graduate of the University of Michigan medical school.
Pharmacia was a pharmaceutical and biotechnological company in Sweden that merged with the American pharmaceutical company Upjohn in 1995. History. Pharmacia company was founded in 1911 in Stockholm, Sweden by pharmacist Gustav Felix Grönfeldt at the Elgen Pharmacy.
Jul 29, 2019 · Mylan and Pfizer announced a definitive agreement to merge Mylan with Upjohn, Pfizer’s off-patent branded and generic medicines business. The new company, expected to have pro forma 2020 revenues of $19 to $20 billion, will be led by Robert J. Coury as Executive Chairman and Michael Goettler as CEO.
